{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:57:23Z","timestamp":1790776643977,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jaci.2023.06.010","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T18:04:02Z","timestamp":1687370642000},"page":"365-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Glimpses into treating GLILD"],"prefix":"10.1016","volume":"152","author":[{"given":"Timi","family":"Martelius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9733-3650","authenticated-orcid":false,"given":"Mikko R.J.","family":"Sepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2023.06.010_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","article-title":"Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency","volume":"114","author":"Bates","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.06.010_bib2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaip.2017.01.021","article-title":"British Lung Foundation\/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders","volume":"5","author":"Hurst","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2023.06.010_bib3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaci.2022.12.813","article-title":"The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease","volume":"152","author":"Smits","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.06.010_bib4","article-title":"Bronchoalveolar lavage fluid reflects a TH1-CD21low B-cell interaction in CVID-related interstitial lung disease","volume":"11","author":"Friedmann","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.06.010_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122728","article-title":"BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency","volume":"4","author":"Maglione","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2023.06.010_bib6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s10875-022-01318-1","article-title":"Raised serum markers of T cell activation and exhaustion in granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"42","author":"Fraz","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.06.010_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaip.2015.07.004","article-title":"Progression of common variable immunodeficiency interstitial lung disease accompanies distinct pulmonary and laboratory findings","volume":"3","author":"Maglione","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2023.06.010_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.606099","article-title":"Treatment strategies for GLILD in common variable immunodeficiency: a systematic review","volume":"12","author":"Lamers","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.06.010_bib9","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jaci.2019.12.896","article-title":"Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score","volume":"145","author":"Tesch","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.06.010_bib10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2020.07.021","article-title":"Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"147","author":"Verbsky","year":"2021","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923008060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923008060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:41:27Z","timestamp":1758793287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674923008060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0091674923008060"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.06.010","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glimpses into treating GLILD","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.12.813","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}